Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohortChristel N Nomden, Richard Pötter, Astrid A C de Leeuw, et al.
ALTEX|October 23, 2025
Towards NAM-based risk assessment for developmental neurotoxic effects, illustrated with chlorpyrifosAnne Zwartsen, Joost Westerhout, Shensheng Zhao, et al.
Cancer Research|May 3, 2003
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumorsLeendert H J Looijenga, Hans Stoop, Hubert P J C de Leeuw, et al.
Cell Reports|December 13, 2018
IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal HematopoiesisHan J M P Verhagen, Noortje van Gils, Tania Martiañez, et al.
Hemasphere|June 8, 2026
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studiesCoen R Veenstra, Lok Lam Ngai, Patrycja Gradowska, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2025
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerJohannes Knoth, Remi A Nout, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysisMax Peters, Astrid A C de Leeuw, Christel N Nomden, et al.
Haematologica|April 30, 2025
Different features of acute myeloid leukemia stem cell quantification in intensively treated patientsLok Lam Ngai, Tom Reuvekamp, Diana Hanekamp, et al.
Haematologica|September 18, 2025
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemiaKathelijn Verdeyen, Tom Reuvekamp, Walter J F M Van der Velden, et al.
Blood|December 15, 2025
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working PartyJacqueline Cloos, Peter J M Valk, Christian Thiede, et al.
Pageof 10